Recent Trends and Innovations in the Management of CLL

Now Viewing

EP: 1.Recent Trends and Innovations in the Management of CLL

EP: 2.CLL Treatment Landscape: Overview of BTK Inhibitors

EP: 3.Evaluating Value of BTK Inhibitors in CLL Treatment

EP: 4.Factors Influencing Choice of Second-Generation BTKi Monotherapy

EP: 5.Empowering Patients: Key Considerations for BTK Inhibitor Adherence

EP: 6.Optimizing Therapy Sequencing in CLL

EP: 7.Leveraging MAICs for Decision-Making in CLL BTK Inhibitor Selection

EP: 8.Decision-Making in CLL: The Role of Real-World Evidence

EP: 9.Combination Regimens with BTK Inhibitors: New Frontiers in CLL Treatment

EP: 10.Financial Challenges of BTK Inhibitor Therapy in CLL: Impact on Access and Utilization

EP: 11.Navigating Access Challenges in CLL Treatment: Strategies for Overcoming Barriers 

EP: 12.The Inflation Reduction Act: Implications for Patient Access in CL

EP: 13.Patient Access Advocacy for BTK Inhibitors

EP: 14.Future Directions of BTK Inhibitors in Leukemia and Lymphoma

Video content above is prompted by the following questions:

• How has the story of CLL treatment evolved in recent history? What are the latest trends and innovations you have observed in the treatment and management of CLL leading up to ASCO 2024?
• Coming into ASCO 2024, what would you consider to be the largest unmet needs in the treatment and management of CLL?